FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

Adverse event software debuts

Free Newsletter

FierceBiotech IT updates senior biotech, pharma, and IT leaders on how IT advances are shaping clinical trials and clinical research. Get your weekly briefing on clinical trial design and management systems, adaptive trials, eClinical trials, and more. Sign up today!



Tools

With September 27, 2009, less than two weeks away, Virtify is betting that small and mid-sized drug makers are scrambling to meet the FDA's adverse event reporting requirements as they go into effect. The company has unveiled a software-as-a-service solution for managing clinical trial disclosure requirements. The Virtx CTRR Clinical Trial Registry & Results solution automates compliance with global regulatory mandates, according to an announcement.

Virtx CTRR is part of the company's ECC Software Suite, an Internet-based solution for managing content and compliance requirements. CTRR automates internal workflow and data gathering processes, as well as external workflow with various global regulatory agencies. The company says it provides lifecycle management of the disclosure process from internal review through approvals, postings, and results maintenance.

Exec VP Stephen Bergson notes that as global standards and regulatory mandates evolve, life sciences companies need to prepare to meet them. He outlined in an interview last month six steps to content compliance. Step one is to automate processes and workflow to minimize errors and discrepancies. Remaining steps address collaborative authoring and evolving standards. 

- here's the announcement
- read the Bergson interview

Related Articles:
Software provides compliant label conversion
Automation is key to compliance


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotechIT Email Newsletter:

More stories about Virtify   adverse event reporting   FDA regulation   Stephen Bergson